Refine
Document Type
- Article (3)
- Doctoral Thesis (1)
Has Fulltext
- yes (4)
Is part of the Bibliography
- no (4)
Keywords
- - (2)
- plasma medicine (2)
- Apoptosis (1)
- CAP (1)
- Cancer (1)
- Cold physical plasma (1)
- HL-60 (1)
- LNCaP (1)
- Oncology (1)
- PC3 (1)
- Plasmamedizin (1)
- ROS (1)
- Reactive oxygen and nitrogen species (1)
- THP-1 (1)
- Therapie des Osteosarkoms (1)
- Tumortherapie (1)
- Urology (1)
- apoptosis (1)
- cancer (1)
- immunomodulation (1)
- kINPen (1)
- osteosarcoma (1)
- plasma oncology (1)
- reactive oxygen species (1)
Institute
- Klinik und Poliklinik für Chirurgie Abt. für Unfall- und Wiederherstellungschirurgie (2)
- Klinik und Poliklinik für Urologie (2)
- Klinik und Poliklinik für Chirurgie Abt. für Viszeral-, Thorax- und Gefäßchirurgie (1)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (1)
: Human osteosarcoma (OS) is the most common primary malignant bone tumor occurring
most commonly in adolescents and young adults. Major improvements in disease-free survival have
been achieved by implementing a combination therapy consisting of radical surgical resection of the
tumor and systemic multi-agent chemotherapy. However, long-term survival remains poor, so novel
targeted therapies to improve outcomes for patients with osteosarcoma remains an area of active
research. This includes immunotherapy, photodynamic therapy, or treatment with nanoparticles.
Cold atmospheric plasma (CAP), a highly reactive (partially) ionized physical state, has been shown
to inherit a significant anticancer capacity, leading to a new field in medicine called “plasma oncology.”
The current article summarizes the potential of CAP in the treatment of human OS and reviews the
underlying molecular mode of action.